Interplayers

Name: Interplayers
Brand: Interplayers

Conectando saúde, transformando vidas.

Est 2000|Valuation $68M|Raised $17M

LinkedIn 64K|Web traffic 60K|FTEs 944|HQ São Paulo, São Paulo, BR

MarketsMarketplace Software

01Competitive Landscape

| Aspect | Interplayers | Vidalink (Competitor A) | ePharma (Competitor B) | |--------|--------------|-------------------------|------------------------| | Starting Price | Not publicly disclosed (sales-led) | Not publicly disclosed in accessible materials | Not publicly disclosed in accessible materials | | Suitable For | Organizations operating in the pharma/distributor/pharmacy ecosystem that require integrated B2B ordering, authorization, and program tooling | Organizations seeking PBM authorization network services (per market positioning; not validated here) | Organizations seeking PBM and benefits administration services (per market positioning; not validated here) | | Key Strength | Portfolio covering ordering, authorization, patient programs, and analytics as presented in vendor materials; claims of broad connectivity in the pharmacy/distributor network | Market positioning as a PBM alternative (per third-party PBM content) | Market positioning as a PBM alternative (per third-party PBM content) | | Key Weakness | Limited third-party software review coverage; some public complaints related to billing/cancellation processes; security certifications not clearly published | Not assessed in this review | Not assessed in this review |

Narrative analysis

- Direct competitors and differentiators - In PBM authorization and benefits administration, Interplayers is referenced alongside Vidalink, ePharma, and Funcional Health Tech in third-party PBM consulting content, indicating a shared competitive set. - Interplayers presents a platform approach combining multiple adjacent workflows (ordering, authorization, analytics, patient program tooling) rather than a single narrow PBM focus. - Feature comparison - Interplayers may be suitable where a single vendor covering multiple adjacent workflows is desirable. Buyers seeking narrowly scoped PBM functionality or clearer public security disclosures may prefer specialized vendors. - Pricing comparison - A rigorous pricing comparison was not possible from the accessible materials due to lack of public price lists for Interplayers and incomplete pricing information for competitors. - Market share and adoption trends - The vendor publishes adoption metrics in its public materials; independent market share data was not obtained in this review. - When customers choose competitors instead - Based on public complaint patterns and available information, some customers—particularly smaller operators—may prefer competitors or simpler solutions that present clearer contracts and offboarding processes.

01Competitive Landscape

Aspect	Interplayers	Vidalink (Competitor A)	ePharma (Competitor B)
Starting Price	Not publicly disclosed (sales-led)	Not publicly disclosed in accessible materials	Not publicly disclosed in accessible materials
Suitable For	Organizations operating in the pharma/distributor/pharmacy ecosystem that require integrated B2B ordering, authorization, and program tooling	Organizations seeking PBM authorization network services (per market positioning; not validated here)	Organizations seeking PBM and benefits administration services (per market positioning; not validated here)
Key Strength	Portfolio covering ordering, authorization, patient programs, and analytics as presented in vendor materials; claims of broad connectivity in the pharmacy/distributor network	Market positioning as a PBM alternative (per third-party PBM content)	Market positioning as a PBM alternative (per third-party PBM content)
Key Weakness	Limited third-party software review coverage; some public complaints related to billing/cancellation processes; security certifications not clearly published	Not assessed in this review	Not assessed in this review

Narrative analysis

Direct competitors and differentiators
- In PBM authorization and benefits administration, Interplayers is referenced alongside Vidalink, ePharma, and Funcional Health Tech in third-party PBM consulting content, indicating a shared competitive set.
- Interplayers presents a platform approach combining multiple adjacent workflows (ordering, authorization, analytics, patient program tooling) rather than a single narrow PBM focus.
Feature comparison
- Interplayers may be suitable where a single vendor covering multiple adjacent workflows is desirable. Buyers seeking narrowly scoped PBM functionality or clearer public security disclosures may prefer specialized vendors.
Pricing comparison
- A rigorous pricing comparison was not possible from the accessible materials due to lack of public price lists for Interplayers and incomplete pricing information for competitors.
Market share and adoption trends
- The vendor publishes adoption metrics in its public materials; independent market share data was not obtained in this review.
When customers choose competitors instead
- Based on public complaint patterns and available information, some customers—particularly smaller operators—may prefer competitors or simpler solutions that present clearer contracts and offboarding processes.